Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret

Toxicology Letters
Kit-Man ChuJ A Rudd

Abstract

Pungent transient receptor potential vanilloid (TRPV1) channel activators have been shown to have broad inhibitory anti-emetic activity against centrally- and peripherally acting challenges but only at doses that have adverse effects on the cardiovascular system and on temperature homeostasis. In the present studies, we investigated the anti-emetic potential of the non-pungent TRPV1 activator, olvanil (0.05-5 mg/kg, s.c., 3 times per day, for 3 days) to antagonise the acute and delayed emesis induced by cisplatin (5 mg/kg, i.p.) in ferrets that had been implanted with radiotelemetry devices to enable an analysis of heart rate and temperature. Cisplatin induced an acute (day 1: 48.0+/-18.3 retches+vomits) and delayed (day 2: 111.7+/-35.5; day 3: 147.5+/-20.2 retches+vomits) emetic response that was associated with reduced food (-98.7% at day 3, P<0.001) and water consumption (-70.2% at day 3, P<0.001) and progressive weight loss (-12.0% at day 3, P<0.001). Olvanil did not prevent either emesis or the weight loss and negative effects on food and water consumption (P>0.05); the effect on food consumption appeared potentiated by a further 21.2% at 0.05 mg/kg (P<0.05) and 19.9% at 0.5 mg/kg (P<0.05). Cisplatin did not alter body tem...Continue Reading

References

Jan 1, 1990·Journal of Neural Transmission. General Section·J MajH Sowińska
Dec 1, 1993·Scandinavian Journal of Psychology·M FredriksonG Steineck
Dec 13, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A Boulant
Jun 16, 2001·European Journal of Pharmacology·V Di MarzoJ J Fernandez-Ruiz
Feb 9, 2002·Brain Research. Molecular Brain Research·Tamas SzaboPeter M Blumberg
Jun 18, 2002·European Journal of Pharmacology·Hisashi YamakuniSeitaro Mutoh
May 15, 2003·Physiological Genomics·Klaas Kramer, Lewis B Kinter
May 7, 2004·European Journal of Biochemistry·Daniel N Cortright, Arpad Szallasi
Jun 3, 2004·Journal of Pharmacological and Toxicological Methods·A P HarrisonM A Unmack
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Karin JordanHans-Joachim Schmoll
Jun 14, 2005·Current Opinion in Chemical Biology·Glenn A ReinhartGary A Gintant
Jan 26, 2006·Cancer Chemotherapy and Pharmacology·Y-L LiuP L R Andrews
May 27, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sik LeeSung Kwang Park
May 19, 2007·Digestive Diseases and Sciences·Fang ZhongKlaus Bielefeldt
Jan 11, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bart C De Jonghe, Charles C Horn
Feb 15, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·A Caitlynn TaylorSean D Stocker
Apr 10, 2008·Journal of Cardiovascular Pharmacology·Yi Zhu, Donna H Wang
Nov 1, 2006·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Isabelle BublotN Joel Edwards

❮ Previous
Next ❯

Citations

Apr 8, 2014·Pharmacology, Biochemistry, and Behavior·Surbhi Gupta, Bhupesh Sharma
May 27, 2016·Temperature : Multidisciplinary Biomedical Journal·John A RuddPaul Lr Andrews
Apr 13, 2013·Journal of Pharmacological and Toxicological Methods·Sonia GoineauVincent Castagné

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.